InvestorsHub Logo
icon url

biomanbaba

07/19/12 8:51 AM

#3402 RE: optionking #3400

the key issues in the short run are whether or not the drug works as well in Humans as in the IND studies and whether COX et al say that it does in their opinion; in their expensive news letters.
In the case that those things occur...and I believe they will the shares could pop from .66 to SEVERAL $. At this time I have no idea where the momentum runs out of gas. It appears we might have an opportunity to use this pop to get a large stake of free shares right away. I am excited about that.